N-(4-(3,5-dimethoxystyryl)phenyl)-2-((5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamide

ID: ALA5281338

Max Phase: Preclinical

Molecular Formula: C27H25N3O5S

Molecular Weight: 503.58

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2nnc(SCC(=O)Nc3ccc(/C=C/c4cc(OC)cc(OC)c4)cc3)o2)cc1

Standard InChI:  InChI=1S/C27H25N3O5S/c1-32-22-12-8-20(9-13-22)26-29-30-27(35-26)36-17-25(31)28-21-10-6-18(7-11-21)4-5-19-14-23(33-2)16-24(15-19)34-3/h4-16H,17H2,1-3H3,(H,28,31)/b5-4+

Standard InChI Key:  NHRPARWJFHYJSC-SNAWJCMRSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   -6.4367   -0.0832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7221    0.3290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0102   -0.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0102   -0.9080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7203   -1.3198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4367   -0.9117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1513    0.3293    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1513    1.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7203   -2.1449    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0057   -2.5576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2956    0.3297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5809   -0.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8663    0.3297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8661    1.1549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1532    1.5656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4383    1.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4368    0.3318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1486   -0.0846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7238    1.5655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0091    1.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7055    1.5655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0091    0.3277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4201    1.1529    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.1347    1.5655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2209    2.3858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0277    2.5573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4401    1.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8882    1.2300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2653    1.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6781    2.5576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5008    2.5568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9135    1.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5044    1.1301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6797    1.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7388    1.8419    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1513    2.5566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  1  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  1  0
 25 24  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
 27 29  1  0
 30 29  2  0
 31 30  1  0
 32 31  2  0
 33 32  1  0
 34 33  2  0
 29 34  1  0
 32 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5281338

    ---

Associated Targets(Human)

SiHa (2051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 503.58Molecular Weight (Monoisotopic): 503.1515AlogP: 5.66#Rotatable Bonds: 10
Polar Surface Area: 95.71Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.68CX Basic pKa: CX LogP: 4.76CX LogD: 4.76
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: -1.33

References

1. Ahmadi R, Ebrahimzadeh MA..  (2020)  Resveratrol - A comprehensive review of recent advances in anticancer drug design and development.,  200  [PMID:32485531] [10.1016/j.ejmech.2020.112356]

Source